MIVACURIUM ION
Traumatic Brain Injury
Joseph D. TobiasSmall moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 73/ 100
Competitive context
66 Active assets in the Traumatic Brain Injury cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
PROPRANOLOL Tanta University | Phase 4 | BBB |
Bxcl501 Universitas Jenderal Soedirman | Phase 4 | BB |
Amantadine SHINKEI Therapeutics, Inc | Phase 4 | BB |
Genotropin Anhui Provincial Hospital | Phase 4 | BB |
Prometrium Minia University | Phase 4 | BB |
View all 50 →
Same molecule, other indications
MIVACURIUM ION is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →